Do analysts prefer AVNS or SNAL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Snail 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is AVNS or SNAL more profitable?

Snail has a net margin of -8.83% compared to Avanos Medical's net margin of -10.39%. Avanos Medical's return on equity of 5.39% beat Snail's return on equity. Company Net Margins Return on Equity Return on Assets Avanos Medical -10.39% 5.39% 3.97% Snail -8.83% -15.49% -13.52%

Does the media favor AVNS or SNAL?

In the previous week, Avanos Medical had 3 more articles in the media than Snail. MarketBeat recorded 7 mentions for Avanos Medical and 4 mentions for Snail. Avanos Medical's average media sentiment score of 1.53 beat Snail's score of 0.19 indicating that Avanos Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avanos Medical 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Snail 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend ICUI or AVNS?

ICU Medical presently has a consensus target price of $192.80, suggesting a potential upside of 10.11%. Given ICU Medical's stronger consensus rating and higher possible upside, research analysts plainly believe ICU Medical is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ICU Medical 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 2.89 Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has preferable valuation and earnings, ICUI or AVNS?

ICU Medical has higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ICU Medical $2.23B 1.96 $730K $1.18 148.39 Avanos Medical $715.90M 1.64 -$72.90M -$1.61 N/A

Does the media refer more to ICUI or AVNS?

In the previous week, ICU Medical had 2 more articles in the media than Avanos Medical. MarketBeat recorded 9 mentions for ICU Medical and 7 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.53 beat ICU Medical's score of 1.37 indicating that Avanos Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ICU Medical 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Avanos Medical 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts rate NVST or AVNS?

Envista currently has a consensus target price of $29.31, indicating a potential upside of 7.95%. Given Envista's stronger consensus rating and higher possible upside, research analysts plainly believe Envista is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Envista 0 Sell rating(s) 9 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.50 Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has preferable valuation & earnings, NVST or AVNS?

Envista has higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Envista $2.86B 1.53 $47M $0.58 46.81 Avanos Medical $715.90M 1.64 -$72.90M -$1.61 N/A

Does the media refer more to NVST or AVNS?

In the previous week, Envista had 5 more articles in the media than Avanos Medical. MarketBeat recorded 12 mentions for Envista and 7 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.53 beat Envista's score of 1.04 indicating that Avanos Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envista 10 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Avanos Medical 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts rate NEOG or AVNS?

Neogen currently has a consensus target price of $12.00, suggesting a potential upside of 2.92%. Given Neogen's stronger consensus rating and higher possible upside, analysts plainly believe Neogen is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neogen 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has better earnings & valuation, NEOG or AVNS?

Neogen has higher revenue and earnings than Avanos Medical. Neogen is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Neogen $870.40M 2.92 -$7.90M -$0.03 N/A Avanos Medical $715.90M 1.64 -$72.90M -$1.61 N/A

Is NEOG or AVNS more profitable?

Neogen has a net margin of -0.91% compared to Avanos Medical's net margin of -10.39%. Avanos Medical's return on equity of 5.39% beat Neogen's return on equity. Company Net Margins Return on Equity Return on Assets Neogen -0.91% 2.78% 1.74% Avanos Medical -10.39% 5.39% 3.97%

Does the media refer more to NEOG or AVNS?

In the previous week, Neogen had 19 more articles in the media than Avanos Medical. MarketBeat recorded 26 mentions for Neogen and 7 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.53 beat Neogen's score of 1.13 indicating that Avanos Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neogen 12 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Avanos Medical 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts recommend AVNS or UFPT?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer AVNS or UFPT?

In the previous week, UFP Technologies had 7 more articles in the media than Avanos Medical. MarketBeat recorded 14 mentions for UFP Technologies and 7 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.53 beat UFP Technologies' score of 1.21 indicating that Avanos Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avanos Medical 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive UFP Technologies 10 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Avanos Medical (AVNS) Competitors

$24.99 0.00 (0.00%)

As of 08/28/2026

Compare

AVNS vs. SNAL, ICUI, NVST, NEOG, and UFPT

Should you buy Avanos Medical stock or one of its competitors? Avanos Medical's main competitors and comparable companies include Snail (SNAL), ICU Medical (ICUI), Envista (NVST), Neogen (NEOG), and UFP Technologies (UFPT). Companies are selected based on similarities in market, industry, and size.

How does Avanos Medical compare to Snail?

Avanos Medical (NYSE:AVNS) and Snail (NASDAQ:SNAL) are related small-cap companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, profitability, analyst recommendations, valuation and media sentiment.

Snail has lower revenue, but higher earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Snail, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A
Snail	$81.23M	0.32	-$27.24M	-$1.26	N/A

95.2% of Avanos Medical shares are owned by institutional investors. Comparatively, 0.4% of Snail shares are owned by institutional investors. 2.3% of Avanos Medical shares are owned by insiders. Comparatively, 66.8% of Snail shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Snail	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Avanos Medical had 3 more articles in the media than Snail. MarketBeat recorded 7 mentions for Avanos Medical and 4 mentions for Snail. Avanos Medical's average media sentiment score of 1.53 beat Snail's score of 0.19 indicating that Avanos Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	7 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Snail	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Avanos Medical has a beta of 1.57, indicating that its share price is 57% more volatile than the broader market. Comparatively, Snail has a beta of 1.29, indicating that its share price is 29% more volatile than the broader market.

Snail has a net margin of -8.83% compared to Avanos Medical's net margin of -10.39%. Avanos Medical's return on equity of 5.39% beat Snail's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
Snail	-8.83%	-15.49%	-13.52%

Summary

Avanos Medical beats Snail on 8 of the 15 factors compared between the two stocks.

How does Avanos Medical compare to ICU Medical?

ICU Medical (NASDAQ:ICUI) and Avanos Medical (NYSE:AVNS) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

ICU Medical has a net margin of 1.39% compared to Avanos Medical's net margin of -10.39%. ICU Medical's return on equity of 7.91% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ICU Medical	1.39%	7.91%	4.17%
Avanos Medical	-10.39%	5.39%	3.97%

96.1% of ICU Medical shares are owned by institutional investors. Comparatively, 95.2% of Avanos Medical shares are owned by institutional investors. 2.1% of ICU Medical shares are owned by insiders. Comparatively, 2.3% of Avanos Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

ICU Medical has higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ICU Medical	$2.23B	1.96	$730K	$1.18	148.39
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A

ICU Medical presently has a consensus target price of $192.80, suggesting a potential upside of 10.11%. Given ICU Medical's stronger consensus rating and higher possible upside, research analysts plainly believe ICU Medical is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ICU Medical	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.89
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, ICU Medical had 2 more articles in the media than Avanos Medical. MarketBeat recorded 9 mentions for ICU Medical and 7 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.53 beat ICU Medical's score of 1.37 indicating that Avanos Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ICU Medical	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Avanos Medical	7 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

ICU Medical has a beta of 0.74, indicating that its stock price is 26% less volatile than the broader market. Comparatively, Avanos Medical has a beta of 1.57, indicating that its stock price is 57% more volatile than the broader market.

Summary

ICU Medical beats Avanos Medical on 14 of the 17 factors compared between the two stocks.

How does Avanos Medical compare to Envista?

Envista (NYSE:NVST) and Avanos Medical (NYSE:AVNS) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, media sentiment, institutional ownership and analyst recommendations.

95.2% of Avanos Medical shares are owned by institutional investors. 1.0% of Envista shares are owned by insiders. Comparatively, 2.3% of Avanos Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Envista had 5 more articles in the media than Avanos Medical. MarketBeat recorded 12 mentions for Envista and 7 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.53 beat Envista's score of 1.04 indicating that Avanos Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envista	10 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Avanos Medical	7 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Envista has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market. Comparatively, Avanos Medical has a beta of 1.57, suggesting that its share price is 57% more volatile than the broader market.

Envista has a net margin of 3.33% compared to Avanos Medical's net margin of -10.39%. Envista's return on equity of 7.88% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	3.33%	7.88%	4.33%
Avanos Medical	-10.39%	5.39%	3.97%

Envista currently has a consensus target price of $29.31, indicating a potential upside of 7.95%. Given Envista's stronger consensus rating and higher possible upside, research analysts plainly believe Envista is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.50
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Envista has higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.86B	1.53	$47M	$0.58	46.81
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A

Summary

Envista beats Avanos Medical on 12 of the 17 factors compared between the two stocks.

How does Avanos Medical compare to Neogen?

Neogen (NASDAQ:NEOG) and Avanos Medical (NYSE:AVNS) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, media sentiment, valuation, profitability and institutional ownership.

Neogen has higher revenue and earnings than Avanos Medical. Neogen is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neogen	$870.40M	2.92	-$7.90M	-$0.03	N/A
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A

In the previous week, Neogen had 19 more articles in the media than Avanos Medical. MarketBeat recorded 26 mentions for Neogen and 7 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.53 beat Neogen's score of 1.13 indicating that Avanos Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Neogen	12 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Avanos Medical	7 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

96.7% of Neogen shares are held by institutional investors. Comparatively, 95.2% of Avanos Medical shares are held by institutional investors. 0.6% of Neogen shares are held by insiders. Comparatively, 2.3% of Avanos Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Neogen has a beta of 1.77, suggesting that its stock price is 77% more volatile than the broader market. Comparatively, Avanos Medical has a beta of 1.57, suggesting that its stock price is 57% more volatile than the broader market.

Neogen has a net margin of -0.91% compared to Avanos Medical's net margin of -10.39%. Avanos Medical's return on equity of 5.39% beat Neogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neogen	-0.91%	2.78%	1.74%
Avanos Medical	-10.39%	5.39%	3.97%

Neogen currently has a consensus target price of $12.00, suggesting a potential upside of 2.92%. Given Neogen's stronger consensus rating and higher possible upside, analysts plainly believe Neogen is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neogen	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

Neogen beats Avanos Medical on 11 of the 16 factors compared between the two stocks.

How does Avanos Medical compare to UFP Technologies?

Avanos Medical (NYSE:AVNS) and UFP Technologies (NASDAQ:UFPT) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, media sentiment, dividends, institutional ownership and earnings.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, UFP Technologies had 7 more articles in the media than Avanos Medical. MarketBeat recorded 14 mentions for UFP Technologies and 7 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.53 beat UFP Technologies' score of 1.21 indicating that Avanos Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	7 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
UFP Technologies	10 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

95.2% of Avanos Medical shares are owned by institutional investors. Comparatively, 87.3% of UFP Technologies shares are owned by institutional investors. 2.3% of Avanos Medical shares are owned by company insiders. Comparatively, 4.6% of UFP Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

UFP Technologies has a net margin of 11.45% compared to Avanos Medical's net margin of -10.39%. UFP Technologies' return on equity of 18.42% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
UFP Technologies	11.45%	18.42%	11.96%

Avanos Medical has a beta of 1.57, indicating that its stock price is 57% more volatile than the broader market. Comparatively, UFP Technologies has a beta of 1.08, indicating that its stock price is 8% more volatile than the broader market.

UFP Technologies has lower revenue, but higher earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A
UFP Technologies	$602.80M	3.86	$68.31M	$9.28	32.33

Summary

UFP Technologies beats Avanos Medical on 10 of the 14 factors compared between the two stocks.

Get Avanos Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AVNS vs. The Competition

Export

Metric	Avanos Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$1.17B	$5.84B	$7.20B	$24.19B
Dividend Yield	N/A	1.75%	2.54%	3.71%
P/E Ratio	-15.52	25.92	273.16	29.99
Price / Sales	1.64	67.90	592.59	19.52
Price / Cash	7.30	33.03	76.74	32.24
Price / Book	1.49	6.18	12.98	7.67
Net Income	-$72.90M	$149.01M	$3.48B	$1.07B
7 Day Performance	N/A	-0.24%	0.13%	-0.32%
1 Month Performance	N/A	6.18%	7.08%	1.84%
1 Year Performance	109.40%	6.30%	24.67%	13.37%

Avanos Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AVNS Avanos Medical	0.5509 of 5 stars	$24.99 flat	N/A	N/A	$1.17B	$715.90M	N/A	2,287	News Coverage Positive News
SNAL Snail	1.3956 of 5 stars	$2.92 -1.2%	N/A	-36.7%	$24.85M	$85.90M	N/A	60	Analyst Downgrade
ICUI ICU Medical	3.4827 of 5 stars	$181.40 -0.6%	$192.80 +6.3%	+37.2%	$4.54B	$2.16B	153.79	13,000	Positive News
NVST Envista	2.992 of 5 stars	$27.06 -1.0%	$29.31 +8.3%	+28.4%	$4.35B	$2.72B	46.68	12,000	News Coverage Positive News
NEOG Neogen	2.2891 of 5 stars	$11.55 -0.4%	$11.67 +1.0%	+102.8%	$2.52B	$870.40M	N/A	2,110	News Coverage Positive News Analyst Upgrade Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AVNS) was last updated on 8/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Avanos Medical (AVNS) Competitors

AVNS vs. SNAL, ICUI, NVST, NEOG, and UFPT

How does Avanos Medical compare to Snail?

Summary

How does Avanos Medical compare to ICU Medical?

Summary

How does Avanos Medical compare to Envista?

Summary

How does Avanos Medical compare to Neogen?

Summary

How does Avanos Medical compare to UFP Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVNS vs. The Competition

Avanos Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Avanos Medical (AVNS) Competitors

AVNS vs. SNAL, ICUI, NVST, NEOG, and UFPT

How does Avanos Medical compare to Snail?

Which has stronger valuation & earnings, AVNS or SNAL?

Do insiders and institutionals believe in AVNS or SNAL?

Do analysts prefer AVNS or SNAL?

Does the media favor AVNS or SNAL?

Which has more volatility and risk, AVNS or SNAL?

Is AVNS or SNAL more profitable?

Summary

How does Avanos Medical compare to ICU Medical?

Is ICUI or AVNS more profitable?

Do insiders & institutionals hold more shares of ICUI or AVNS?

Which has preferable valuation and earnings, ICUI or AVNS?

Do analysts recommend ICUI or AVNS?

Does the media refer more to ICUI or AVNS?

Which has more volatility and risk, ICUI or AVNS?

Summary

How does Avanos Medical compare to Envista?

Do insiders and institutionals believe in NVST or AVNS?

Does the media refer more to NVST or AVNS?

Which has more volatility and risk, NVST or AVNS?

Is NVST or AVNS more profitable?

Do analysts rate NVST or AVNS?

Which has preferable valuation & earnings, NVST or AVNS?

Summary

How does Avanos Medical compare to Neogen?

Which has better earnings & valuation, NEOG or AVNS?

Does the media refer more to NEOG or AVNS?

Do institutionals and insiders have more ownership in NEOG or AVNS?

Which has more risk and volatility, NEOG or AVNS?

Is NEOG or AVNS more profitable?

Do analysts rate NEOG or AVNS?

Summary

How does Avanos Medical compare to UFP Technologies?

Do analysts recommend AVNS or UFPT?

Does the media prefer AVNS or UFPT?

Do insiders and institutionals hold more shares of AVNS or UFPT?

Is AVNS or UFPT more profitable?

Which has more volatility & risk, AVNS or UFPT?

Which has preferable earnings & valuation, AVNS or UFPT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVNS vs. The Competition

Avanos Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools